Literature DB >> 11091273

Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis.

K V Clemons1, G Grunig, R A Sobel, L F Mirels, D M Rennick, D A Stevens.   

Abstract

IL-10 is associated with a Th2 response, down-regulation of a Th1 response and macrophage activation. We assessed the role of IL-10 during systemic infection with Aspergillus fumigatus. Systemic aspergillosis was established in female C56B1/6 IL-10(-/-) (KO) and wild-type (WT) C57B1/6 mice by i.v. administration of 1 x 10(5)-6 x 10(5) conidia of A. fumigatus. In two experiments, KO survived longer than did WT (P < 0.001). Determination of fungal burdens in the kidneys and brain showed that KO carried significantly lower burdens in both organs than did WT on day 3 (P < 0.001). Semiquantitative histological analyses showed fewer inflammatory foci/mm2 in brain and kidneys of KO than WT (P < 0.03 and < 0.001, respectively) and that extent of infection and associated tissue injury were greater in WT. Although beneficial in some bacterial infections, exogenous IL-10 has been shown deleterious in models of fungal infection. Our data indicate IL-10 is deleterious during systemic aspergillosis infection, increasing the host susceptibility to lethal infection. We speculate this might be related to greater Th2 or lesser Th1 responses, or down-regulation of macrophage responses, in WT compared with KO.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11091273      PMCID: PMC1905763          DOI: 10.1046/j.1365-2249.2000.01382.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

1.  Regulatory role of exogenous IL-10 in the development of immune response versus Cryptococcus neoformans.

Authors:  C Monari; C Retini; B Palazzetti; F Bistoni; A Vecchiarelli
Journal:  Clin Exp Immunol       Date:  1997-08       Impact factor: 4.330

2.  Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes.

Authors:  A Vecchiarelli; C Retini; C Monari; C Tascini; F Bistoni; T R Kozel
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Cyclosporine and itraconazole interaction in heart and lung transplant recipients.

Authors:  M R Kramer; S E Marshall; D W Denning; A M Keogh; R M Tucker; J N Galgiani; N J Lewiston; D A Stevens; J Theodore
Journal:  Ann Intern Med       Date:  1990-08-15       Impact factor: 25.391

4.  Aspergillus wound infection following laparostomy.

Authors:  G L Carlson; M M Mughal; M Birch; D W Denning
Journal:  J Infect       Date:  1996-09       Impact factor: 6.072

Review 5.  Interleukin-10 gene knock-out mice: a model of chronic inflammation.

Authors:  D Rennick; N Davidson; D Berg
Journal:  Clin Immunol Immunopathol       Date:  1995-09

6.  Epidemiology of invasive aspergillosis in European cancer centres. EORTC Invasive Fungal Infections Cooperative Group.

Authors:  J Cohen; D W Denning; M A Viviani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

7.  Th1 and Th2 cytokines in mice with invasive aspergillosis.

Authors:  E Cenci; S Perito; K H Enssle; P Mosci; J P Latgé; L Romani; F Bistoni
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

Review 8.  Paracoccidioidomycosis: an update.

Authors:  E Brummer; E Castaneda; A Restrepo
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

Review 9.  Immunosuppressive and anti-inflammatory properties of interleukin 10.

Authors:  J E de Vries
Journal:  Ann Med       Date:  1995-10       Impact factor: 4.709

10.  Efficacy of oral saperconazole in systemic murine aspergillosis.

Authors:  L H Hanson; K V Clemons; D W Denning; D A Stevens
Journal:  J Med Vet Mycol       Date:  1995 Sep-Oct
View more
  31 in total

1.  Efficacy of micafungin alone or in combination against systemic murine aspergillosis.

Authors:  Javier Capilla Luque; Karl V Clemons; David A Stevens
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

Review 2.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis.

Authors:  Viviane Balloy; Michel Huerre; Jean-Paul Latgé; Michel Chignard
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 4.  Innate immunity to Aspergillus species.

Authors:  Stacy J Park; Borna Mehrad
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

Review 5.  Host immune defense against Aspergillus fumigatus: insight from experimental systemic (disseminated) infection.

Authors:  I Mirkov; S Stosic-Grujicic; M Kataranovski
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

6.  Autocrine IL-10 Signaling Promotes Dendritic Cell Type-2 Activation and Persistence of Murine Cryptococcal Lung Infection.

Authors:  Seagal Teitz-Tennenbaum; Steven P Viglianti; Jonathan A Roussey; Stuart M Levitz; Michal A Olszewski; John J Osterholzer
Journal:  J Immunol       Date:  2018-08-10       Impact factor: 5.422

7.  Repeated exposure to Aspergillus fumigatus conidia results in CD4+ T cell-dependent and -independent pulmonary arterial remodeling in a mixed Th1/Th2/Th17 microenvironment that requires interleukin-4 (IL-4) and IL-10.

Authors:  Andrew B Shreiner; Benjamin J Murdock; Amir A Sadighi Akha; Nicole R Falkowski; Paul J Christensen; Eric S White; Cory M Hogaboam; Gary B Huffnagle
Journal:  Infect Immun       Date:  2011-11-07       Impact factor: 3.441

8.  Evaluation of the in vitro activity of voriconazole as predictive of in vivo outcome in a murine Aspergillus fumigatus infection model.

Authors:  Valentina Salas; F Javier Pastor; Enrique Calvo; Deanna A Sutton; Annette W Fothergill; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

9.  Binding of live conidia of Aspergillus fumigatus activates in vitro-generated human Langerhans cells via a lectin of galactomannan specificity.

Authors:  F Persat; N Noirey; J Diana; M-J Gariazzo; D Schmitt; S Picot; C Vincent
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

10.  CC chemokine receptor 7 expression by effector/memory CD4+ T cells depends on antigen specificity and tissue localization during influenza A virus infection.

Authors:  Gudrun F Debes; Kerstin Bonhagen; Thorsten Wolff; Ute Kretschmer; Stefan Krautwald; Thomas Kamradt; Alf Hamann
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.